Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion type Assertion NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_head.
- NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion description "[Although HER2 protein overexpression and amplification were rare and did not correlate with clinicopathological parameters, further studies will be necessary to answer the question as to whether adjuvant therapy targeting the HER2 receptor might improve outcome in patients with a SIC with HER2 gene amplification and protein overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_provenance.
- NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion evidence source_evidence_literature NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_provenance.
- NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion SIO_000772 23703294 NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_provenance.
- NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion wasDerivedFrom befree-20150227 NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_provenance.
- NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_assertion wasGeneratedBy ECO_0000203 NP379503.RAceEIDY9ozIn6j_tdAkSXyQKCoHw3O3G4QPPaYESQLLw130_provenance.